메뉴 건너뛰기




Volumn 53, Issue 7, 2009, Pages 2707-2713

Piperaquine pharmacodynamics and parasite viability in a murine malaria model

Author keywords

[No Author keywords available]

Indexed keywords

PIPERAQUINE;

EID: 67649994372     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00056-09     Document Type: Article
Times cited : (8)

References (33)
  • 2
  • 5
    • 0037115230 scopus 로고    scopus 로고
    • Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria
    • Denis, M. B., T. M. E. Davis, S. Hewitt, S. Incardona, K. Nimol, T. Fandeur, Y. Poravuth, C. Lim, and D. Socheat. 2002. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35:1469-1476.
    • (2002) Clin. Infect. Dis , vol.35 , pp. 1469-1476
    • Denis, M.B.1    Davis, T.M.E.2    Hewitt, S.3    Incardona, S.4    Nimol, K.5    Fandeur, T.6    Poravuth, Y.7    Lim, C.8    Socheat, D.9
  • 6
    • 33947499544 scopus 로고    scopus 로고
    • Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: Superior efficacy and post-treatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria
    • Hasugian, A. R., H. L. E. Purba, R. M. Wuwung, E. P. Ebsworth, R. Maristela, P. M. P. Penttinen, F. Laihad, N. M. Anstey, and R. N. Price. 2007. Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and post-treatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin. Infect. Dis. 44:1067-1074.
    • (2007) Clin. Infect. Dis , vol.44 , pp. 1067-1074
    • Hasugian, A.R.1    Purba, H.L.E.2    Wuwung, R.M.3    Ebsworth, E.P.4    Maristela, R.5    Penttinen, P.M.P.6    Laihad, F.7    Anstey, N.M.8    Price, R.N.9
  • 8
  • 9
    • 0038359611 scopus 로고    scopus 로고
    • Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection
    • Hung, T.-Y., T. M. E. Davis, and K. Ilett. 2003. Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 791:93-101.
    • (2003) J. Chromatogr. B , vol.791 , pp. 93-101
    • Hung, T.-Y.1    Davis, T.M.E.2    Ilett, K.3
  • 11
  • 12
    • 0346057805 scopus 로고    scopus 로고
    • Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria
    • Karunajeewa, H., C. Lim, T.-Y. Hung, K. Ilett, M. B. Denis, D. Socheat, and T. M. E. Davis. 2003. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br. J. Clin. Pharmacol. 57:93-99.
    • (2003) Br. J. Clin. Pharmacol , vol.57 , pp. 93-99
    • Karunajeewa, H.1    Lim, C.2    Hung, T.-Y.3    Ilett, K.4    Denis, M.B.5    Socheat, D.6    Davis, T.M.E.7
  • 15
    • 34848881280 scopus 로고    scopus 로고
    • Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers
    • Liu, C., R. Zhang, X. Hong, T. Huang, S. Mi, and N. Wang. 2007. Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers. Yakugaku Zasshi 127:1709-1714.
    • (2007) Yakugaku Zasshi , vol.127 , pp. 1709-1714
    • Liu, C.1    Zhang, R.2    Hong, X.3    Huang, T.4    Mi, S.5    Wang, N.6
  • 16
    • 0036061753 scopus 로고    scopus 로고
    • Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria
    • Long, T. T. A., S. Nakazawa, M. C. Huaman, and H. Kanbara. 2002. Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria. Clin. Diagn. Lab. Immunol. 9:933-934.
    • (2002) Clin. Diagn. Lab. Immunol , vol.9 , pp. 933-934
    • Long, T.T.A.1    Nakazawa, S.2    Huaman, M.C.3    Kanbara, H.4
  • 19
    • 40649125563 scopus 로고    scopus 로고
    • Plasmodium berghei: Parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model
    • Moore, B. R., J. D. Jago, and K. T. Batty. 2008. Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model. Exp. Parasitol. 118:458-467.
    • (2008) Exp. Parasitol , vol.118 , pp. 458-467
    • Moore, B.R.1    Jago, J.D.2    Batty, K.T.3
  • 21
    • 0036078913 scopus 로고    scopus 로고
    • Combination therapy for malaria: The way forward?
    • Nosten, F., and P. Brasseur. 2002. Combination therapy for malaria: the way forward? Drugs 62:1315-1329.
    • (2002) Drugs , vol.62 , pp. 1315-1329
    • Nosten, F.1    Brasseur, P.2
  • 22
    • 0035139250 scopus 로고    scopus 로고
    • Current status of malaria and potential for control
    • Phillips, R. S. 2001. Current status of malaria and potential for control. Clin. Microbiol. Rev. 14:208-226.
    • (2001) Clin. Microbiol. Rev , vol.14 , pp. 208-226
    • Phillips, R.S.1
  • 24
    • 45349085248 scopus 로고    scopus 로고
    • Dihydroartemisinin- piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: A preliminary report
    • Rijkin, M. J., R. McGready, M. E. Boel, M. Barends, S. Proux, M. Pimanpanarak, P. Singhasivanon, and F. Nosten. 2008. Dihydroartemisinin- piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Am. J. Trop. Med. Hyg. 78:543-545.
    • (2008) Am. J. Trop. Med. Hyg , vol.78 , pp. 543-545
    • Rijkin, M.J.1    McGready, R.2    Boel, M.E.3    Barends, M.4    Proux, S.5    Pimanpanarak, M.6    Singhasivanon, P.7    Nosten, F.8
  • 26
    • 33646508357 scopus 로고    scopus 로고
    • Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects
    • Roshammar, D., T. N. Hai, S. F. Hietala, N. V. Huong, and M. Ashton. 2006. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur. J. Clin. Pharmacol. 62:335-341.
    • (2006) Eur. J. Clin. Pharmacol , vol.62 , pp. 335-341
    • Roshammar, D.1    Hai, T.N.2    Hietala, S.F.3    Huong, N.V.4    Ashton, M.5
  • 30
    • 30344465041 scopus 로고    scopus 로고
    • Tangpukdee, N., S. Krudswood, K. Chalermrut, C. Pengruksa, S. Sriviairit, U. Silachamroon, P. Wilairtana, S. Phongtananant, S. Kano, and S. Looareesuwan. 2005. An open, randomized clinical trial of Artekin vs. artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36:1085-1091.
    • Tangpukdee, N., S. Krudswood, K. Chalermrut, C. Pengruksa, S. Sriviairit, U. Silachamroon, P. Wilairtana, S. Phongtananant, S. Kano, and S. Looareesuwan. 2005. An open, randomized clinical trial of Artekin vs. artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J. Trop. Med. Public Health 36:1085-1091.
  • 31
    • 40549113955 scopus 로고    scopus 로고
    • Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand
    • Tarning, J., E. A. Ashley, N. Lindegardh, K. Stepniewska, L. Phaiphun, N. P. J. Day, R. McGready, M. Ashton, F. Nosten, and N. J. White. 2008. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob. Agents Chemother. 52:1052-1061.
    • (2008) Antimicrob. Agents Chemother , vol.52 , pp. 1052-1061
    • Tarning, J.1    Ashley, E.A.2    Lindegardh, N.3    Stepniewska, K.4    Phaiphun, L.5    Day, N.P.J.6    McGready, R.7    Ashton, M.8    Nosten, F.9    White, N.J.10
  • 33
    • 0027470164 scopus 로고
    • Treatment of Plasmodium falciparum malaria with PSD: Selective pressure for resistance is a function of long elimination half life
    • Watkins, W. M., and M. Mosobo. 1993. Treatment of Plasmodium falciparum malaria with PSD: selective pressure for resistance is a function of long elimination half life. Trans. R. Soc. Trop. Med. Hyg. 87:75-78.
    • (1993) Trans. R. Soc. Trop. Med. Hyg , vol.87 , pp. 75-78
    • Watkins, W.M.1    Mosobo, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.